Gao, Shugeng <br/><br/>
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  05 2020 
 - 816-826 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1016/j.jtho.2020.01.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Humans<br/>Immune Checkpoint Inhibitors<br/>Lung Neoplasms--drug therapy<br/>Neoadjuvant Therapy